Esperimento alla Cleveland Clinic, allevia preoccupazioni
Risultati per: Sclerosi multipla e legame con il virus della mononucleosi
Questo è quello che abbiamo trovato per te
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
New England Journal of Medicine, Volume 389, Issue 9, Page 808-819, August 2023.
La teoria del caos si applica anche ai virus, incluso il Covid
Palù: aiuterà nel controllo delle future emergenze pandemiche
Zanzare positive al virus Usutu a Oristano, primo caso del 2023
Si attende conferma da Istituto zooprofilattico di Teramo
L'Unione Europea autorizza il primo vaccino contro il virus sinciziale
Per proteggere gli anziani e i bambini fino a sei mesi di età
Ue autorizza vaccino Pfizer contro virus sinciziale
Proteggere gli anziani e i bambini fino a sei mesi di età
Despite Efficacy of Treatment, Mortality Remains High After Hepatitis C Virus Cure
The leading causes of death are drug-related and liver disease–related.
Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus
Circulation, Ahead of Print. BACKGROUND:Cardiac reprogramming is a technique to directly convert nonmyocytes into myocardial cells using genes or small molecules. This intervention provides functional benefit to the rodent heart when delivered at the time of myocardial infarction or activated transgenically up to 4 weeks after myocardial infarction. Yet, several hurdles have prevented the advancement of cardiac reprogramming for clinical use.METHODS:Through a combination of screening and rational design, we identified a cardiac reprogramming cocktail that can be encoded in a single adeno-associated virus. We also created a novel adeno-associated virus capsid that can transduce cardiac fibroblasts more efficiently than available parental serotypes by mutating posttranslationally modified capsid residues. Because a constitutive promoter was needed to drive high expression of these cell fate–altering reprogramming factors, we included binding sites to a cardiomyocyte-restricted microRNA within the 3’ untranslated region of the expression cassette that limits expression to nonmyocytes. After optimizing this expression cassette to reprogram human cardiac fibroblasts into induced cardiomyocyte-like cells in vitro, we also tested the ability of this capsid/cassette combination to confer functional benefit in acute mouse myocardial infarction and chronic rat myocardial infarction models.RESULTS:We demonstrated sustained, dose-dependent improvement in cardiac function when treating a rat model 2 weeks after myocardial infarction, showing that cardiac reprogramming, when delivered in a single, clinically relevant adeno-associated virus vector, can support functional improvement in the postremodeled heart. This benefit was not observed with GFP (green fluorescent protein) or a hepatocyte reprogramming cocktail and was achieved even in the presence of immunosuppression, supporting myocyte formation as the underlying mechanism.CONCLUSIONS:Collectively, these results advance the application of cardiac reprogramming gene therapy as a viable therapeutic approach to treat chronic heart failure resulting from ischemic injury.
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease
New England Journal of Medicine, Volume 389, Issue 7, Page 676-676, August 2023.
Aids, scoperta una nuova via con cui il virus invade le cellule
Da ricercatori italiani e americani. Utile anche contro i tumori
Farmaci, c'è un possibile legame tra gastroprotettori e demenza
(EMBARGO: 22) Rischio riscontrato solo con assunzione prolungata
Cracking the host functional network involved in hepatitis B virus cccDNA biology
Hepatitis B virus (HBV) causes chronic infection in at least 250 million people worldwide, resulting in approximately 850 000 deaths annually. Chronic carriers are at risk of developing severe liver disease including decompensated cirrhosis and hepatocellular carcinoma (HCC). HBV infection can be prevented with a highly effective prophylactic vaccine. Viraemia can be suppressed with nucleos/tide analogues targeting the HBV polymerase, but standard-of-care therapy rarely leads to a cure leaving patients requiring lifelong therapy to prevent relapse of viral replication. Furthermore, even on treatment patients remain at a residual risk of developing HCC. Development of treatments resulting in a functional cure has been hampered by our incomplete understanding of HBV persistence and the difficulty of targeting pharmacologically essential steps in the viral replicative cycle.1 HBV is a partially double-stranded DNA virus of the Hepadnaviridae family, which has a complex replication cycle and is intricately intertwined with the host cell DNA…
Febbre del Nilo, zanzare positive al virus nell'Oristanese
I campioni all’Istituto Zooprofilattico Sperimentale di Teramo
Epatiti: 8mila infezioni al giorno nel mondo, ma ora l’obiettivo è eradicare il virus
Possono causare infezioni croniche e gravi problemi al fegato. Più di un milione di persone muore ogni anno per le conseguenze derivanti da queste malattie
Umbria fra le prime Regioni per la prevenzione del papilloma virus
Recepite le nuove linee guida
La carica dei virus estivi, i più a rischio sono i bambini
Pediatra: attenzione a cibi mal conservati, sabbia e piscinette